Who
Linda Maxwell
Director
Company insider
Files Form 4 as: Director, United Therapeutics; Director, ImmunityBio.
In numbers
- Trades disclosed
- 21
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $456K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 10 Sep 2020
- Last trade
- 22 Jul 2026
- Last filed
- 23 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Jul 2026filed 23 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —380 at $0.00 | filing |
| 22 Jul 2026filed 23 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,190 at $0.00 | filing |
| 22 Jul 2026filed 23 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —380 at $0.00 | filing |
| 22 Jul 2026filed 23 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,190 at $0.00 | filing |
| 9 Jun 2026filed 10 Jun 2026 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —65,600 at $0.00 | filing |
| 9 Jun 2026filed 10 Jun 2026 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —65,600 at $0.00 | filing |
| 24 Jul 2025filed 28 Jul 2025 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,650 at $0.00 | filing |
| 18 Jun 2025filed 20 Jun 2025 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —162,786 at $0.00 | filing |
| 25 Jul 2024filed 26 Jul 2024 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,890 at $0.00 | filing |
| 11 Jun 2024filed 13 Jun 2024 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —77,633 at $0.00 | filing |
| 13 Jul 2023filed 17 Jul 2023 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,560 at $0.00 | filing |
| 13 Jun 2023filed 15 Jun 2023 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —158,263 at $0.00 | filing |
| 7 Jul 2022filed 8 Jul 2022 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,980 at $0.00 | filing |
| 14 Jun 2022filed 15 Jun 2022 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —167,937 at $0.00 | filing |
| 27 May 2022filed 27 May 2022 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,000 at $0.00 | filing |
| 27 May 2022filed 27 May 2022 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Code M | $205K2,000 at $102.44 | filing |
| 27 May 2022filed 27 May 2022 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $456K2,000 at $228.00 | filing |
| 8 Jul 2021filed 9 Jul 2021 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $1.2M6,450 at $183.98 | filing |
| 10 Jun 2021filed 14 Jun 2021 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —26,064 at $0.00 | filing |
| 3 May 2021filed 5 May 2021 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —21,873 at $0.00 | filing |
News
Prosecutors claim Maine man admitted to murder of Linda Maxwellwmtw.com · 6 Oct 2026Contrasting Xenon Pharmaceuticals (NASDAQ:XENE) and United Therapeutics (NASDAQ:UTHR)UTHR · dailypolitical.com · 18 Oct 2026United Therapeutics (NASDAQ: UTHR) general counsel sells 8,300 shares under planUTHR · themarketsdaily.com · 17 Oct 2026Head to Head Survey: Xenon Pharmaceuticals (NASDAQ:XENE) vs. United Therapeutics (NASDAQ:UTHR)UTHR · themarketsdaily.com · 12 Oct 2026
1 headline in the last 90 days name Linda Maxwell; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.